Journal of Peking University(Health Sciences) ›› 2015, Vol. 47 ›› Issue (4): 597-600. doi: 10.3969/j.issn.1671-167X.2015.04.009

• Articles • Previous Articles     Next Articles

Efficacy and outcome of palliative TURP in patients with bladder outlet obstruction induced by advanced prostate cancer

LIU Lei, HOU Xiao-fei△, MA Lu-lin, ZHAO Lei, ZHANG Hong-xian   

  1. (Department of Urology, Peking University Third Hospital, Beijing 100191, China)
  • Online:2015-08-18 Published:2015-08-18
  • Contact: HOU Xiao-fei E-mail:houxf12@163.com

Abstract:

Objective: To evaluate the efficacy and outcome of palliative transurethral resection of the prostate (pTURP) in patients with server bladder outlet obstruction (BOO) due to prostatic obstruction induced by advanced prostate cancer.Methods:All the 16 patients who had a pTURP between November 2007 and January 2015 due to BOO (high residual urine volume combined with hydronephrosis or urinary retention refractory to medical treatment ) at our institution were retrospectively assessed. All the patients were diagnosed with advanced prostate cancer (Ⅲ stage or Ⅳ stage). The clinical data, functional and oncological follow-up results were evaluated. The cancer specific survivals were estimated by Kaplan-Meier analysis.Results:The mean age of the patients was 73.8 years (63-81 years). Five  cases were graded in stage Ⅲ of prostate cancer and 11  in stage Ⅳ. The indications for pTURP were refractory urinary retention in 12 cases, and high residual urine volume with hydronephrosis in 4 cases. The mean prostate volume at pTURP was 43.2 mL (28-78 mL) and the mean PSA (prostate specific antigen) level before pTURP was 48.2 μg/L (2-107 μg/L). The patients had mean residual urine volume 166.4 mL (50-450 mL) and mean urinary flow rate 3.6 mL/s(0-6 mL/s, n=7) before pTURP. It took mean 62.9min (35-94 min) in pTURP with mean estimated blood loss 126.9 mL (30-263 mL) and mean resected tissue 14.1 g (10-22 g). There were no transfusion cases. Postoperative mean serum PSA 20.5 μg/L (1-41 μg/L), residual urine volume 43.4 mL (0-400 mL) and urinary flow rate 10.1 mL/s (7-16 mL/s, n=7) were shown in these cases. A patient encountered persistent hematuria needing irrigation. Compared with preoperation, the patients had significantly lower serum PSA level (P<0.001), less residual urine volume (P<0.001) and more urinary flow rate (P=0.001) after pTURP. The mean follow-up after pTURP was 36 months (1-86 months). In addition, 2 patients received repeated pTURP. At the time of the latest analysis, 3 patients died from prostate cancer progression. As estimated by KaplanMeier analysis, the 2-, 3- and 5-year cancer specific survival rates after pTURP were 91%, 78% and 58%, respectively.Conclusion:Despite less resected tissue, greater delay in urination and reoperation rates, pTURP is a fairly effective procedure in patients with server BOO . Although a potential negative impact of pTURP on survival cannot be excluded, the estimated 3 and 5year cancer specific survival rates in this series seem to justify this intervention.

Key words: Prostatic neoplasms, Urinary bladder neck obstruction, Transurethral resection of prostate

CLC Number: 

  • R737.25
[1] Zhicun LI, Tianyu WU, Lei LIANG, Yu FAN, Yisen MENG, Qian ZHANG. Risk factors analysis and nomogram model construction of postoperative pathological upgrade of prostate cancer patients with single core positive biopsy [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 896-901.
[2] Yuxuan TIAN,Mingjian RUAN,Yi LIU,Derun LI,Jingyun WU,Qi SHEN,Yu FAN,Jie JIN. Predictive effect of the dual-parametric MRI modified maximum diameter of the lesions with PI-RADS 4 and 5 on the clinically significant prostate cancer [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 567-574.
[3] Kaifeng YAO,Mingjian RUAN,Derun LI,Yuxuan TIAN,Yuke CHEN,Yu FAN,Yi LIU. Diagnostic efficacy of targeted biopsy combined with regional systematic biopsy in prostate cancer in patients with PI-RADS 4-5 [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 575-581.
[4] Junyong OU,Kunming NI,Lulin MA,Guoliang WANG,Ye YAN,Bin YANG,Gengwu LI,Haodong SONG,Min LU,Jianfei YE,Shudong ZHANG. Prognostic factors of patients with muscle invasive bladder cancer with intermediate-to-high risk prostate cancer [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 582-588.
[5] Yi LIU,Chang-wei YUAN,Jing-yun WU,Qi SHEN,Jiang-xi XIAO,Zheng ZHAO,Xiao-ying WANG,Xue-song LI,Zhi-song HE,Li-qun ZHOU. Diagnostic efficacy of prostate cancer using targeted biopsy with 6-core systematic biopsy for patients with PI-RADS 5 [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 812-817.
[6] Chang-wei YUAN,De-run LI,Zhi-hua LI,Yi LIU,Gang-zhi SHAN,Xue-song LI,Li-qun ZHOU. Application of dynamic contrast enhanced status in multiparametric magnetic resonance imaging for prostatic cancer with PI-RADS 4 lesion [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 838-842.
[7] Su-huan XU,Bei-bei WANG,Qiu-ying PANG,Li-jun ZHONG,Yan-ming DING,Yan-bo HUANG,Xin-yan CHE. Effect of equal temperature bladder irrigation in patients with transurethral resection of prostate: A meta-analysis [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 676-683.
[8] Yi-chang HAO,Ye YAN,Fan ZHANG,Min QIU,Lang ZHOU,Ke LIU,Jian LU,Chun-lei XIAO,Yi HUANG,Cheng LIU,Lu-lin MA. Surgical strategy selection and experience summary of prostate cancer with positive single needle biopsy [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 625-631.
[9] Yi LIU,Zhi-jian LIU,Qi SHEN,Jing-yun WU,Yu FAN,De-run LI,Wei YU,Zhi-song HE. A clinical analysis of 14 cases of prostatic stromal tumor of uncertain malignant potential [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 621-624.
[10] Ye YAN,Hai-zhui XIA,Xu-sheng LI,Wei HE,Xue-hua ZHU,Zhi-ying ZHANG,Chun-lei XIAO,Yu-qing LIU,Hua HUANG,Liang-hua HE,Jian LU. Application of U-shaped convolutional neural network in auto segmentation and reconstruction of 3D prostate model in laparoscopic prostatectomy navigation [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 596-601.
[11] ZHANG Fan, XIAO Chun-lei, ZHANG Shu-dong, HUANG Yi, MA Lu-lin. Relationship between recovery of urinary continence after laparoscopic radical prostatectomy and prostatic volume and intravesical prostatic protursion length [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 621-625.
[12] BI Yong-xiang, XIAO Min-hui, ZHANG Ning-nan, LI Xiao-yun, MAO Xiao-peng, ZHANG Ke, ZHANG Zhuo-rui, ZHAO Liang-yun. Construction and improvement of animal models with different positional osseous metastasis of prostate cancer in vivo [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 590-596.
[13] LIU Zhuo, LUO Cheng, HU Shuai, FAN Yu, LIU Zhen-hua, YANG Xin-yu, SHEN Qi, LIU Li-bo, HAN Wen-ke, ZHOU Li-qun, YU Wei, HE Qun, ZHANG Qian, JIN Jie. Diagnosis and treatment of T1a-T1b prostate cancer [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 812-816.
[14] WANG Gong-wei, SHEN Dan-hua, ZHANG Wei-Yu, XU Ke-xin, XU Tao, HU Hao. Trends in Gleason scores of Chinese prostate carcinoma from 1995 to 2014 [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 801-805.
[15] LIU Zhuo, MA Lu-lin, ZHANG Shu-dong, LU Min, TIAN Yu, HE Qun, JIN Jie. Basal cell carcinoma of prostate: a report of three cases [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 720-724.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!